Stem Cell: market research reports

Market Research > Browse Research > Life Sciences > Biotechnology

Stem cells are unique in that they are undifferentiated cells that can differentiate to become virtually any type of cell in the body (totipotent). They therefore represent an ongoing source of the specialized cells that make up the tissues and organs. There is great interest in stem cells because they have potential to replace defective or damaged cells resulting from a variety of disorders and injuries, leading to a range of new regenerative therapies.

Stem cells also have value as a research tool, as their in vitro study would allow scientists to learn more about the function of various organs and the development of particular diseases; stem cells may also eventually permit drug developers to test emerging therapies on diseased cells.

Cells must meet very specific criteria in order to be termed stem cells. They must: produce copies themselves; proliferate at a rapid rate; and display certain proteins on their surface that indicate a capacity to differentiate into other tissues, such as bone and cartilage. A stem cell line is a group of cells that all descend from a single original stem cell. Symmetric division gives rise to two identical daughter cells both endowed with stem cell properties. Asymmetric division produces only one stem cell and a progenitor cell with limited self-renewal potential.

Stem Cell market research reports and industry analysis

Cancer Stem Cells Drug Pipeline Update 2014 3/25/2014 \| published by: BioSeeker Group AB ... development and cancer drugs which are inhibitors of the Hedgehog, Notch, and WNT Pathway. These developmental pathways are frequently activated in neoplasms, and particularly in the rare subpopulation of cancer stem cells. There are today ... \| read more...	$5,622.50
Circulating Tumor Cells and Cancer Stem Cells Technologies 3/1/2014 \| published by: Global Industry Analysts ... US, Canada, Japan, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2013 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics ... \| read more...	$4,950.00
High Throughput Screening (HTS) Market by Technology (Cell Based, Ultra High Throughput Screening (uHTS), Label Free, Bioinformatics), by Apllications (Target Identification, Primary Screening, Toxicology, Stem Cell) & by End Users (Pharmaceutical Industr 2/4/2014 \| published by: MarketsandMarkets ... CRO) - Forecast to 2018 “Technological Advancements and Flourishing Outsourcing Industry Likely to Propel the Growth of the Global High Throughput Screening (HTS) Market” In this report, the global high throughput screening (HTS) market has ... \| read more...	$4,650.00
Complete 2013-14 Induce Pluripotent Stem Cell Industy Report 2/1/2014 \| published by: BioInformant Worldwide, L.L.C. ... replicate repeatedly. In addition, their “unspecialized” nature allows them to differentiate into a wide variety of specialized cell types. The possibilities arising from these characteristics have caused great commercial interest, with potential applications ranging from ... \| read more...	$3,495.00
Cell Therapy Deals and Alliances of 2013 2/1/2014 \| published by: Current Partnering ... healthcare companies during 2013. Using these reports, dealmakers will effectively and efficiently gain insight into the partnering activities of the past year. The report series allows you to view all the partnering and alliances deals ... \| read more...	$1,495.00
MediPoint: Bone Grafts and Substitutes - South American Analysis and Market Forecasts 1/31/2014 \| published by: GlobalData ... has resulted in a gradual shift towards increased adoption of bone grafts and substitutes (BGS), especially in the US and European markets. In contrast to the general picture in developed countries, autograft bone still represents ... \| read more...	$4,450.00
MediPoint: Bone Grafts and Substitutes - APAC Analysis and Market Forecasts 1/31/2014 \| published by: GlobalData ... resulted in a gradual shift towards increased adoption of bone grafts and substitutes (BGS), especially in the US and European markets. In contrast to the general picture in developed countries, autograft bone still represents the ... \| read more...	$4,450.00
MediPoint: Bone Grafts and Substitutes - EU Analysis and Market Forecasts 1/31/2014 \| published by: GlobalData ... resulted in a gradual shift towards increased adoption of bone grafts and substitutes (BGS), especially in the US and European markets. In contrast to the general picture in developed countries, autograft bone still represents the ... \| read more...	$4,450.00
Mice Model Market - by Type [Inbred, Knockout, Conditioned], Technology [Microinjection, Embryonic Stem Cell], Disease [Oncology, Immunology, CNS], Service [Breeding, Cryopreservation, Quarantine] & Care Products [Cages, Bedding, Feed] - Forecasts to 2018 1/6/2014 \| published by: MarketsandMarkets ... years, the mice model market, which includes models and services, has witnessed many innovations that have led to an increase in the application areas of mice models. For instance, mice models are widely used in ... \| read more...	$5,650.00
Neural Control Trends 1/1/2014 \| published by: Global Industry Analysts ... the prospective application areas. In addition, the report also expounds the drawbacks of cyborg insects. Neural control, also known as neural interaction or neural interfacing, is touted to emerge as a revolutionary technology and a ... \| read more...	$950.00
Cancer Stem Cell Trends 1/1/2014 \| published by: Global Industry Analysts ... of diseases such as cancer and the reimbursement assistance by regulatory organizations in developed nations including the US and Europe. Cancer Stem Cells (CSCs) are the cells within a tumor that possess the capability of ... \| read more...	$1,450.00
Analyzing the Biotechnology Industry in India 1/1/2014 \| published by: Aruvian's R'search ... the country's biotech industry, the Indian biotechnology market has witnessed remarkable growth in recent years. The biotech industry in India did not bear the brunt of the recent economic recession and in fact due to ... \| read more...	$500.00
Circulating Tumor Cell (CTC) Diagnostics: Technologies and Global Markets 1/1/2014 \| published by: BCC Research ... reach nearly $8.9 billion by 2018, demonstrating a compound annual growth rate (CAGR) of 18.9% for the five-year period, 2013 to 2018. This report provides: An overview of the global market for cancer diagnostics based ... \| read more...	$6,650.00
Mesenchymal Stem Cells 1/1/2014 \| published by: Global Industry Analysts ... Annual estimates and forecasts are provided for the period 2009 through 2018. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. ... \| read more...	$4,950.00
Plunkett's Health Care Technologies Overview 2014: A Summary Excerpted from Plunkett's Health Care Industry Almanac 2014 11/12/2013 \| published by: Plunkett Research, Ltd. ... Research Online Link to our 5-minute video overview of this industry Pages: 76 Statistical Tables Provided: 40 Geographic Focus: Global A condensed market research report excerpted from Plunkett’s Health Care Industry Almanac 2014, including forecasts ... \| read more...	$199.99
Plunkett's Health Care Industry Trends & Statistics 2014: A Summary Version of Plunkett's Health Care Industry Almanac 2014 11/12/2013 \| published by: Plunkett Research, Ltd. ... at Plunkett Research Online Link to our 5-minute video overview of this industry Pages: 79 Statistical Tables Provided: 40 Geographic Focus: Global A condensed market research report excerpted from Plunkett’s Health Care Industry Almanac 2014, ... \| read more...	$199.99
Capitalizing on Opportunities in Cord Blood Industry Growth (2013 Version) 11/1/2013 \| published by: BioInformant Worldwide, L.L.C. ... as of 2005, and now there are 485 worldwide. Cord blood banks now exist within 98 different countries around the world. That is a 21-fold increase (2,100%) in the companies involved in the industry, in ... \| read more...	$3,995.00
Opportunities in Human Embryonic Stem Cell (hESC) Products - Trends and Forecasts to 2017 10/1/2013 \| published by: BioInformant Worldwide, L.L.C. ... to differentiate into any mature cell type. Categorized by stage of life, several broad categories of stem cells exist, including: Embryonic stem cells, derived from blastocysts Post-natal stem cells, derived from newborn tissues Adult stem ... \| read more...	$3,495.00
ADME-Toxicology Testing 10/1/2013 \| published by: Global Industry Analysts ... the US, Canada, Japan, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2009 through 2018. The report profiles 75 companies including many key and niche players such as ... \| read more...	$4,950.00
Plunkett's Biotech and Genetics Industry Almanac 2014: Biotech and Genetics Industry Market Research, Statistics, Trends and Leading Companies 9/26/2013 \| published by: Plunkett Research, Ltd. ... companies Industry Glossary Buyer may register for free access to search and export data at Plunkett Research Online Link to our 5-minute video overview of this industry Pages: 592 Statistical Tables Provided: 16 Companies Profiled: ... \| read more...	$349.99
Plunkett's Biotech and Genetics Industry Trends and Statistics 2014: A Summary Version of Plunkett's Biotech and Genetics Industry Almanac 2014 9/26/2013 \| published by: Plunkett Research, Ltd. ... 72 Statistical Tables Provided: 16 Geographic Focus: Global A condensed market research report excerpted from Plunkett’s Biotech & Genetics Industry Almanac 2014, including forecasts and market estimates, technologies analysis and vital statistical tables. You will ... \| read more...	$199.99
Nerve Repair and Regeneration Market by Xenografts (Conduits, Protectors), Neuromodulation [Internal (Spinal Cord, Deep Brain)], External (Transcranial Magnetic)], Surgery [Direct Nerve Repair, Grafting, Stem Cell] - Global Trend and Forecast to 2018 9/9/2013 \| published by: MarketsandMarkets ... repair and regeneration market was worth $4.1 billion in 2012 and is expected to grow at a CAGR of 11.5% in the next five years, primarily due to technological advancements and favorable reimbursement policies. The ... \| read more...	$4,650.00
Complete 2013-14 U.S. Cord Blood Banking Industry Report 9/1/2013 \| published by: BioInformant Worldwide, L.L.C. ... now exist in nearly every developed country, as well as within several developing nations. That is a 21-fold increase (2,100%) in the companies involved in the industry in less than a ten-year period. Within the ... \| read more...	$3,995.00
Hematopoietic Stem Cell Transplantation - Pipeline Review, H2 2013 8/30/2013 \| published by: Global Markets Direct ... of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Hematopoietic Stem Cell Transplantation, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players ... \| read more...	$2,000.00
Global Stem Cell Anticancer Therapeutics Market 2012-2016 8/16/2013 \| published by: Infiniti Research Limited - TechNavio ... of the key factors contributing to this market growth. The Global Stem Anticancer Therapeutics market has also been witnessing an increasing number of strategic alliances among vendors. However, stringent regulatory approval processes could pose a ... \| read more...	$2,000.00

< prev 1 2 3 4 5 next >

Our Clients